| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 17 | 2025 | 941 | 1.600 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2022 | 490 | 1.170 |
Why?
|
| Myelin Proteins | 2 | 2016 | 76 | 1.020 |
Why?
|
| Hand Deformities, Congenital | 3 | 2021 | 89 | 0.960 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2021 | 214 | 0.880 |
Why?
|
| INDEL Mutation | 2 | 2020 | 88 | 0.840 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 159 | 0.770 |
Why?
|
| Transcription Factors | 6 | 2025 | 2585 | 0.760 |
Why?
|
| Micrognathism | 1 | 2021 | 65 | 0.750 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 9 | 0.750 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 140 | 0.710 |
Why?
|
| Rare Diseases | 1 | 2022 | 185 | 0.710 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 964 | 0.710 |
Why?
|
| Chromosome Disorders | 3 | 2019 | 309 | 0.700 |
Why?
|
| Gene Duplication | 3 | 2016 | 358 | 0.670 |
Why?
|
| Chromosome Duplication | 4 | 2018 | 147 | 0.670 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2016 | 371 | 0.660 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 26 | 0.620 |
Why?
|
| Genomics | 5 | 2024 | 1478 | 0.610 |
Why?
|
| Haploinsufficiency | 5 | 2021 | 247 | 0.600 |
Why?
|
| Gene Deletion | 2 | 2021 | 794 | 0.570 |
Why?
|
| Genome, Human | 6 | 2025 | 1267 | 0.550 |
Why?
|
| Gene Rearrangement | 2 | 2015 | 326 | 0.550 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2019 | 448 | 0.530 |
Why?
|
| Smith-Magenis Syndrome | 2 | 2016 | 105 | 0.530 |
Why?
|
| Intellectual Disability | 3 | 2021 | 1043 | 0.510 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 39 | 0.510 |
Why?
|
| Exons | 4 | 2025 | 795 | 0.500 |
Why?
|
| Membrane Proteins | 4 | 2019 | 1530 | 0.490 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2015 | 199 | 0.460 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 647 | 0.460 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2025 | 531 | 0.460 |
Why?
|
| Exome | 6 | 2022 | 1041 | 0.430 |
Why?
|
| Chromosome Aberrations | 5 | 2022 | 614 | 0.430 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 1582 | 0.410 |
Why?
|
| Mutation | 10 | 2023 | 5773 | 0.400 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 672 | 0.400 |
Why?
|
| Mouth Neoplasms | 2 | 2023 | 82 | 0.400 |
Why?
|
| Phenotype | 8 | 2020 | 4227 | 0.390 |
Why?
|
| Comparative Genomic Hybridization | 7 | 2022 | 574 | 0.380 |
Why?
|
| Trans-Activators | 3 | 2025 | 809 | 0.380 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 530 | 0.360 |
Why?
|
| Genomic Instability | 3 | 2022 | 229 | 0.340 |
Why?
|
| Homologous Recombination | 2 | 2022 | 92 | 0.330 |
Why?
|
| Humans | 40 | 2025 | 123213 | 0.300 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 481 | 0.300 |
Why?
|
| DNA Replication | 4 | 2019 | 343 | 0.300 |
Why?
|
| Alleles | 3 | 2018 | 1603 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2023 | 651 | 0.290 |
Why?
|
| Mosaicism | 2 | 2022 | 240 | 0.280 |
Why?
|
| Adenosine Triphosphatases | 2 | 2016 | 208 | 0.230 |
Why?
|
| Genomic Structural Variation | 2 | 2015 | 79 | 0.230 |
Why?
|
| Retrospective Studies | 6 | 2022 | 16019 | 0.230 |
Why?
|
| Child, Preschool | 11 | 2021 | 13888 | 0.230 |
Why?
|
| Muscle Hypotonia | 2 | 2022 | 185 | 0.220 |
Why?
|
| Meningioma | 1 | 2025 | 120 | 0.220 |
Why?
|
| Pedigree | 8 | 2021 | 1584 | 0.220 |
Why?
|
| Population Health | 1 | 2024 | 37 | 0.220 |
Why?
|
| Base Sequence | 4 | 2022 | 3091 | 0.210 |
Why?
|
| Pharmacogenetics | 1 | 2024 | 183 | 0.210 |
Why?
|
| Child | 11 | 2025 | 24244 | 0.210 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 183 | 0.210 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 12 | 0.210 |
Why?
|
| Carrier Proteins | 2 | 2018 | 1019 | 0.200 |
Why?
|
| Genes, ras | 1 | 2022 | 96 | 0.200 |
Why?
|
| Nervous System Diseases | 2 | 2016 | 372 | 0.200 |
Why?
|
| Adolescent | 9 | 2021 | 19124 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 715 | 0.200 |
Why?
|
| Muscular Diseases | 1 | 2022 | 102 | 0.200 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 10 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 156 | 0.190 |
Why?
|
| Precision Medicine | 1 | 2024 | 313 | 0.180 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 699 | 0.180 |
Why?
|
| Megalencephaly | 1 | 2021 | 58 | 0.180 |
Why?
|
| Female | 19 | 2021 | 65516 | 0.180 |
Why?
|
| Male | 20 | 2025 | 60117 | 0.170 |
Why?
|
| Neutrophils | 1 | 2022 | 372 | 0.170 |
Why?
|
| Cytokines | 2 | 2023 | 1285 | 0.170 |
Why?
|
| Infant | 11 | 2022 | 12347 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 353 | 0.170 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 1758 | 0.170 |
Why?
|
| Actins | 1 | 2021 | 340 | 0.170 |
Why?
|
| Chromosome Inversion | 2 | 2016 | 76 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2019 | 100 | 0.160 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 44 | 0.150 |
Why?
|
| Germ Cells | 2 | 2022 | 192 | 0.150 |
Why?
|
| Models, Genetic | 3 | 2017 | 766 | 0.150 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 123 | 0.150 |
Why?
|
| Gametogenesis | 2 | 2017 | 24 | 0.150 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 61 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2018 | 4705 | 0.150 |
Why?
|
| Homozygote | 2 | 2017 | 533 | 0.150 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 123 | 0.150 |
Why?
|
| Microcephaly | 1 | 2021 | 328 | 0.150 |
Why?
|
| Alu Elements | 2 | 2015 | 64 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 467 | 0.150 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.140 |
Why?
|
| Gene Dosage | 2 | 2015 | 441 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 554 | 0.140 |
Why?
|
| SUMO-1 Protein | 1 | 2016 | 8 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 2586 | 0.140 |
Why?
|
| Gene Frequency | 1 | 2018 | 713 | 0.140 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 140 | 0.140 |
Why?
|
| Facies | 1 | 2017 | 155 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 2047 | 0.140 |
Why?
|
| Sumoylation | 1 | 2016 | 33 | 0.130 |
Why?
|
| Genetic Testing | 2 | 2021 | 995 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2018 | 609 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2020 | 847 | 0.130 |
Why?
|
| Primates | 1 | 2015 | 81 | 0.130 |
Why?
|
| Language Development Disorders | 1 | 2017 | 173 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 83 | 0.120 |
Why?
|
| Acromegaly | 1 | 2015 | 8 | 0.120 |
Why?
|
| Gigantism | 1 | 2015 | 14 | 0.120 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2015 | 22 | 0.120 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2015 | 27 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 550 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 239 | 0.120 |
Why?
|
| Campomelic Dysplasia | 1 | 2014 | 5 | 0.120 |
Why?
|
| Animals | 7 | 2023 | 33761 | 0.120 |
Why?
|
| Foot Deformities, Congenital | 1 | 2014 | 16 | 0.120 |
Why?
|
| Fibula | 1 | 2014 | 20 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 863 | 0.120 |
Why?
|
| Toes | 1 | 2014 | 26 | 0.120 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 347 | 0.120 |
Why?
|
| Syndactyly | 1 | 2014 | 24 | 0.120 |
Why?
|
| Fibrillar Collagens | 1 | 2014 | 15 | 0.120 |
Why?
|
| Founder Effect | 1 | 2014 | 31 | 0.120 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2014 | 29 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 269 | 0.120 |
Why?
|
| Fingers | 1 | 2014 | 65 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2016 | 200 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 353 | 0.120 |
Why?
|
| Tibia | 1 | 2014 | 70 | 0.120 |
Why?
|
| Haplotypes | 1 | 2015 | 519 | 0.110 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 442 | 0.110 |
Why?
|
| Osteochondrodysplasias | 1 | 2014 | 68 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 455 | 0.110 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 97 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2022 | 757 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2020 | 1480 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3084 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 351 | 0.110 |
Why?
|
| Cell Movement | 1 | 2016 | 831 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 190 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 313 | 0.100 |
Why?
|
| Computational Biology | 1 | 2017 | 798 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1266 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 5047 | 0.100 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 378 | 0.100 |
Why?
|
| Mitochondria | 1 | 2016 | 677 | 0.100 |
Why?
|
| Mice | 3 | 2023 | 17496 | 0.090 |
Why?
|
| Karyotyping | 2 | 2022 | 330 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1806 | 0.080 |
Why?
|
| Adult | 6 | 2021 | 29091 | 0.070 |
Why?
|
| Translocation, Genetic | 2 | 2022 | 352 | 0.070 |
Why?
|
| Young Adult | 5 | 2021 | 8886 | 0.070 |
Why?
|
| Prognosis | 1 | 2015 | 4507 | 0.070 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 286 | 0.070 |
Why?
|
| Chromosome Breakpoints | 2 | 2017 | 80 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3868 | 0.060 |
Why?
|
| Pharmacogenomic Testing | 1 | 2024 | 37 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2024 | 36 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2016 | 4493 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2024 | 60 | 0.060 |
Why?
|
| Brain | 1 | 2015 | 2962 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2015 | 623 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 2017 | 527 | 0.050 |
Why?
|
| Genetic Loci | 2 | 2015 | 333 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 2020 | 738 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2023 | 104 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2022 | 78 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 2696 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 92 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2022 | 213 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2025 | 1012 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 237 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 394 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2021 | 90 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 139 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2020 | 248 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 105 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2019 | 8107 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 348 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 225 | 0.040 |
Why?
|
| Neuroglia | 1 | 2020 | 193 | 0.040 |
Why?
|
| Neurons | 2 | 2020 | 1933 | 0.040 |
Why?
|
| Genotype | 2 | 2014 | 2541 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 657 | 0.040 |
Why?
|
| Zebrafish | 1 | 2020 | 386 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 106 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 638 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 1593 | 0.030 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2016 | 5 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 85 | 0.030 |
Why?
|
| Consanguinity | 1 | 2017 | 107 | 0.030 |
Why?
|
| A549 Cells | 1 | 2016 | 44 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2016 | 67 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2017 | 125 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1740 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 45 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 114 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 94 | 0.030 |
Why?
|
| COS Cells | 1 | 2016 | 273 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 2016 | 47 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 288 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 874 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 54 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 209 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 707 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 809 | 0.030 |
Why?
|
| Spastin | 1 | 2014 | 8 | 0.030 |
Why?
|
| Prostaglandins F | 1 | 2014 | 9 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 345 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2014 | 41 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 58 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 543 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 170 | 0.030 |
Why?
|
| Clone Cells | 1 | 2014 | 163 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2014 | 168 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2015 | 157 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 83 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2014 | 152 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1115 | 0.030 |
Why?
|
| Axons | 1 | 2016 | 381 | 0.030 |
Why?
|
| Adenoma | 1 | 2015 | 133 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 126 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 408 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 382 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 470 | 0.030 |
Why?
|
| Cell Division | 1 | 2014 | 780 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 4276 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 987 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2014 | 313 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 572 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 485 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 747 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 821 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 878 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 761 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 478 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 766 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1422 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2842 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1592 | 0.020 |
Why?
|
| United States | 1 | 2024 | 10633 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 19089 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2306 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 6033 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7147 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 26009 | 0.010 |
Why?
|